Skip to content

KR-MEDICAL

Active
Private limited companyfounded 2024active for 2 yearsFrans Vekemansstraat 151, 1120 Brussel, BelgiumKBO/BCE: BE 1004.407.581

From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette

Summary

KR-MEDICAL has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €21,704 and a net result of €11,704. Its solvency ranks better than 14% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 09-01-2024 Normal situation
Registered office
11 active companies are registered at this address 2 started in the 12 months before. Source: KBO register, as of 1 November 2026.
Activity
General medical practice NACE 86210
Establishment unit
2.354.357.769 1120 Brussel, since 09-01-2024
Financial year end
30 June
Peppol
Reachable since 16-12-2025

Board and ownership

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts to 30-06-2025
Gross margin
€82,183
Turnover
≈ €180,000
estimated
Profit
€11,704
Equity
€21,704
Total assets
€205,042
Staff
≈ 0.7 FTE
estimated
Filed on 05-01-2026, 26 days before the deadlinePDF
Score breakdownraises riskEquity €21,704 (10.6% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €205,042Liquidity: current ratio 1.45, cash €34,690Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 27% of micro companies in human health (NACE 86)
Financial strength
Average
Solvency 36
equity 10.6% of total assets
Liquidity 70
short-term debt 12.5% · cash 16.9%
Profitability 73
return on assets 5.7%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 02-2025: 0.3% 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.5%▲ +0.1 percentage points vs 12-2025highest value 02-2026: 0.1%▼ -0.4 percentage points vs 01-2026lowest value 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026lowest value 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.45, below the usual 1.5. Short-term debt is 12.5% and cash 16.9% of total assets. 89.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 15% of them on solvency, 50% on liquidity and 17% on profitability.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €205,042
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €21,704 (10.6% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.45, cash €34,690
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 14%
← weakest strongest →
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 05-01-2026, 26 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
26 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Caution: Lower solvency than 85% of companies in human healthsector median 63.0% · 20,678 companies 10.6% View

Comparable companies

These companies have the same main activity as KR-MEDICAL: general medical practice (NACE 86210). They are comparable in size and age: total assets between €179,000 and €232,000, founded in 2023.

CompanyTotal assetsGross margin
KR-MEDICAL Brussel€205,042€82,183
L’ENTRE ACTE MEDICAL Brussel€184,156€78,698
Dr. Demie De Coster Bilzen-Hoeselt€231,591€80,027
Dr. Bart Kortrijk€183,890€88,741
Cabinet Médical FANARA Laura Chapelle-lez-Herlaimont€181,729€76,991
Dr. Elizabet Damen, pediater Aalst€208,622€82,617
Huisarts Elke Vanhee Zwevegem€178,893€82,487
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about KR-MEDICAL

What is the company number of KR-MEDICAL?
The company number of KR-MEDICAL is 1004.407.581. The VAT number is the same number with BE in front: BE 1004.407.581.
Where is KR-MEDICAL based?
The registered office is at Frans Vekemansstraat 151, 1120 Brussel.Company details
What does KR-MEDICAL do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of KR-MEDICAL?
The legal form of KR-MEDICAL is Private limited company (BV).
When was KR-MEDICAL founded?
KR-MEDICAL was founded on 09-01-2024.
Is KR-MEDICAL still active?
Yes, KR-MEDICAL is an active enterprise in the KBO register.
What is the turnover of KR-MEDICAL?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €82,183 and 32 comparable companies (NACE 862). It probably lies between €140,000 and €240,000.Financials
Is KR-MEDICAL profitable?
In financial year 2025, KR-MEDICAL made a profit of €11,704.
Where can I find the annual accounts of KR-MEDICAL?
KR-MEDICAL filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts 2025 (PDF)

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.